Takeda sees OTC role in emerging markets

10 May 2013 - Deborah Wilkes


OTC medicines and branded generics will play an important role at Takeda, as the Japanese pharmaceutical company puts emerging markets at the centre of its plans.

Click tags below for more information on topics:


Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: